l-carnitine supplementation to reverse hyperammonemia in Inherited Metabolic Diseases | Cellular and Molecular Neurobiology L‐carnitine for valproic acid‐induced toxicity
Lcarnitine for valproic acidinduced toxicity PMC Mitochondrial hepatopathy: Anticipated difficulties in management of fatty acid oxidation defects and urea cycle defects Valproic Acid Toxicity Peripheral Brain Quantitative systems pharmacology Model to characterize valproic acid induced hyperammonemia and the effect of L carnitine supplementation ScienceDirect
Pay in 4 interest-free payments of $5.01 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



